4 June 2020 News
AstraZeneca has partnered with Accent Therapeutics for the discovery, development and commercialisation of new medicines to treat cancer.
28 May 2020 News
Gilead Sciences has partnered with Arcus Biosciences to jointly develop and commercialise current and future cancer therapeutic candidates in the latter’s pipeline.
28 May 2020 Comment
While chemotherapies have historically been the main treatment approach in oncology, the arrival of immunotherapies, which increase the immune system’s anti-tumour ability with fewer side effects, has shifted the treatment...
18 May 2020 Analysis
During the ongoing Covid-19 pandemic, the FDA has continued in its normal role of approving safe and effective drugs. But how do pharma companies go about bringing a new drug...
13 May 2020 Comment
At the 2020 annual American Association for Cancer Research (AACR) conference on 27-28 April, a new option for the treatment of metastatic melanoma patients with BRAFV600 mutations was presented. Specifically,...
11 May 2020 Analysis
Genocea’s ATLAS platform can determine the best target for each individual cancer patient, primarily by identifying and excluding a new type of antigen, called an Inhibigen, which can undermine a...
4 May 2020 Analysis
The VC wings of three big pharma companies – Novartis, Pfizer and the Merck group – have all continued their support for Swiss oncology biotech FoRx in its seed round....
30 April 2020 Analysis
Start-up company Peptomyc is looking to develop a ‘universal cancer treatment’, which inhibits an oncoprotein called Myc that is integral to the mechanism of cancer cells. The company has described...
28 April 2020 Comment
More than half of age-related macular degeneration cases go undiagnosed in major pharmaceutical markets
Age-related macular degeneration (AMD) is a progressive eye disease that affects the retina, the area of the eye responsible for central vision and sharpness. AMD is the most common cause...
22 April 2020 Comment
As the Covid-19 pandemic escalates, the spread of the infection is putting increasing pressure on healthcare systems worldwide. While valuable medical resources are being diverted for management of the Covid-19...